0 followers
Kalgene is developing a novel fusion protein therapeutic for slowing the progression of Alzheimer’s disease, with technology licensed from the National Research Council of Canada.
Astellas Pharma
40 followers
Tilray
19 followers
Knight Therapeutics
1 follower
AstraZeneca
408 followers
Bayer
312 followers
Bristol-Myers Squibb
250 followers
UCB
45 followers
NYU Langone Health
23 followers
Perrigo
16 followers
West Pharmaceutical Services
8 followers
Dechra Pharmaceuticals
9 followers
Explore companies